 | • レポートコード：QFJ1-3898 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、胆管がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5-フルオロウラシル（5-FU）、ゲムシタビン、シスプラチン、カペシタビン、オキサリプラチン、その他）、用途別市場規模（病院＆診療所、がん治療センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胆管がん治療薬の市場動向 ・企業の競争状況、市場シェア ・胆管がん治療薬の種類別市場規模と予測2016-2027（5-フルオロウラシル（5-FU）、ゲムシタビン、シスプラチン、カペシタビン、オキサリプラチン、その他） ・胆管がん治療薬の用途別市場規模と予測2016-2027（病院＆診療所、がん治療センター、その他） ・胆管がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・胆管がん治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胆管がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胆管がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・胆管がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Celgene、Mylan、Eli Lilly、Johnson & Johnson、Accord Healthcare、Roche、Teva、AbbVie、Bristol-Myers Squibb、Pfizer、Intercept Pharmaceuticals、Novartis、Sanofi、Kyowa Hakko Kirin、Delcath Systems、Fresenius Kabi） ・結論 |
Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unknown, but few factors that cause bile duct cancer are long-term inflammation in the liver, biliary stones, abnormalities in bile duct such as cysts, infection with liver fluke parasites leading to bile duct leading to cancer, and exposure to harmful chemicals or toxins. Major symptoms associated with bile duct cancer include jaundice, weight loss, loss of appetite, discoloration of urine and stool, abdominal pain, itching, and fever. Some drugs used to treat bile duct cancer include 5-fluorouracil (5-fu), gemcitabine, cisplatin, capecitabine and oxaliplatin.
Market Analysis and Insights: Global Bile Duct Cancer Drugs Market
The global Bile Duct Cancer Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bile Duct Cancer Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bile Duct Cancer Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bile Duct Cancer Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bile Duct Cancer Drugs market.
Global Bile Duct Cancer Drugs Scope and Market Size
Bile Duct Cancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bile Duct Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
5-Fluorouracil (5-FU)
Gemcitabine
Cisplatin
Capecitabine
Oxaliplatin
Others
Segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Celgene
Mylan
Eli Lilly
Johnson & Johnson
Accord Healthcare
Roche
Teva
AbbVie
Bristol-Myers Squibb
Pfizer
Intercept Pharmaceuticals
Novartis
Sanofi
Kyowa Hakko Kirin
Delcath Systems
Fresenius Kabi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bile Duct Cancer Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 5-Fluorouracil (5-FU)
1.2.3 Gemcitabine
1.2.4 Cisplatin
1.2.5 Capecitabine
1.2.6 Oxaliplatin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bile Duct Cancer Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bile Duct Cancer Drugs Market Perspective (2016-2027)
2.2 Bile Duct Cancer Drugs Growth Trends by Regions
2.2.1 Bile Duct Cancer Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bile Duct Cancer Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Bile Duct Cancer Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Bile Duct Cancer Drugs Industry Dynamic
2.3.1 Bile Duct Cancer Drugs Market Trends
2.3.2 Bile Duct Cancer Drugs Market Drivers
2.3.3 Bile Duct Cancer Drugs Market Challenges
2.3.4 Bile Duct Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bile Duct Cancer Drugs Players by Revenue
3.1.1 Global Top Bile Duct Cancer Drugs Players by Revenue (2016-2021)
3.1.2 Global Bile Duct Cancer Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Bile Duct Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bile Duct Cancer Drugs Revenue
3.4 Global Bile Duct Cancer Drugs Market Concentration Ratio
3.4.1 Global Bile Duct Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bile Duct Cancer Drugs Revenue in 2020
3.5 Bile Duct Cancer Drugs Key Players Head office and Area Served
3.6 Key Players Bile Duct Cancer Drugs Product Solution and Service
3.7 Date of Enter into Bile Duct Cancer Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bile Duct Cancer Drugs Breakdown Data by Type
4.1 Global Bile Duct Cancer Drugs Historic Market Size by Type (2016-2021)
4.2 Global Bile Duct Cancer Drugs Forecasted Market Size by Type (2022-2027)
5 Bile Duct Cancer Drugs Breakdown Data by Application
5.1 Global Bile Duct Cancer Drugs Historic Market Size by Application (2016-2021)
5.2 Global Bile Duct Cancer Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bile Duct Cancer Drugs Market Size (2016-2027)
6.2 North America Bile Duct Cancer Drugs Market Size by Type
6.2.1 North America Bile Duct Cancer Drugs Market Size by Type (2016-2021)
6.2.2 North America Bile Duct Cancer Drugs Market Size by Type (2022-2027)
6.2.3 North America Bile Duct Cancer Drugs Market Size by Type (2016-2027)
6.3 North America Bile Duct Cancer Drugs Market Size by Application
6.3.1 North America Bile Duct Cancer Drugs Market Size by Application (2016-2021)
6.3.2 North America Bile Duct Cancer Drugs Market Size by Application (2022-2027)
6.3.3 North America Bile Duct Cancer Drugs Market Size by Application (2016-2027)
6.4 North America Bile Duct Cancer Drugs Market Size by Country
6.4.1 North America Bile Duct Cancer Drugs Market Size by Country (2016-2021)
6.4.2 North America Bile Duct Cancer Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bile Duct Cancer Drugs Market Size (2016-2027)
7.2 Europe Bile Duct Cancer Drugs Market Size by Type
7.2.1 Europe Bile Duct Cancer Drugs Market Size by Type (2016-2021)
7.2.2 Europe Bile Duct Cancer Drugs Market Size by Type (2022-2027)
7.2.3 Europe Bile Duct Cancer Drugs Market Size by Type (2016-2027)
7.3 Europe Bile Duct Cancer Drugs Market Size by Application
7.3.1 Europe Bile Duct Cancer Drugs Market Size by Application (2016-2021)
7.3.2 Europe Bile Duct Cancer Drugs Market Size by Application (2022-2027)
7.3.3 Europe Bile Duct Cancer Drugs Market Size by Application (2016-2027)
7.4 Europe Bile Duct Cancer Drugs Market Size by Country
7.4.1 Europe Bile Duct Cancer Drugs Market Size by Country (2016-2021)
7.4.2 Europe Bile Duct Cancer Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bile Duct Cancer Drugs Market Size (2016-2027)
8.2 Asia-Pacific Bile Duct Cancer Drugs Market Size by Type
8.2.1 Asia-Pacific Bile Duct Cancer Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bile Duct Cancer Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bile Duct Cancer Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Bile Duct Cancer Drugs Market Size by Application
8.3.1 Asia-Pacific Bile Duct Cancer Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bile Duct Cancer Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bile Duct Cancer Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Bile Duct Cancer Drugs Market Size by Region
8.4.1 Asia-Pacific Bile Duct Cancer Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bile Duct Cancer Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bile Duct Cancer Drugs Market Size (2016-2027)
9.2 Latin America Bile Duct Cancer Drugs Market Size by Type
9.2.1 Latin America Bile Duct Cancer Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Bile Duct Cancer Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Bile Duct Cancer Drugs Market Size by Type (2016-2027)
9.3 Latin America Bile Duct Cancer Drugs Market Size by Application
9.3.1 Latin America Bile Duct Cancer Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Bile Duct Cancer Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Bile Duct Cancer Drugs Market Size by Application (2016-2027)
9.4 Latin America Bile Duct Cancer Drugs Market Size by Country
9.4.1 Latin America Bile Duct Cancer Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Bile Duct Cancer Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bile Duct Cancer Drugs Market Size (2016-2027)
10.2 Middle East & Africa Bile Duct Cancer Drugs Market Size by Type
10.2.1 Middle East & Africa Bile Duct Cancer Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bile Duct Cancer Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bile Duct Cancer Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Bile Duct Cancer Drugs Market Size by Application
10.3.1 Middle East & Africa Bile Duct Cancer Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bile Duct Cancer Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bile Duct Cancer Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Bile Duct Cancer Drugs Market Size by Country
10.4.1 Middle East & Africa Bile Duct Cancer Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bile Duct Cancer Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Celgene
11.1.1 Celgene Company Details
11.1.2 Celgene Business Overview
11.1.3 Celgene Bile Duct Cancer Drugs Introduction
11.1.4 Celgene Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.1.5 Celgene Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Bile Duct Cancer Drugs Introduction
11.2.4 Mylan Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Bile Duct Cancer Drugs Introduction
11.3.4 Eli Lilly Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Bile Duct Cancer Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Details
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Bile Duct Cancer Drugs Introduction
11.5.4 Accord Healthcare Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.5.5 Accord Healthcare Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Bile Duct Cancer Drugs Introduction
11.6.4 Roche Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Bile Duct Cancer Drugs Introduction
11.7.4 Teva Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.7.5 Teva Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Bile Duct Cancer Drugs Introduction
11.8.4 AbbVie Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Bile Duct Cancer Drugs Introduction
11.9.4 Bristol-Myers Squibb Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Bile Duct Cancer Drugs Introduction
11.10.4 Pfizer Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Intercept Pharmaceuticals
11.11.1 Intercept Pharmaceuticals Company Details
11.11.2 Intercept Pharmaceuticals Business Overview
11.11.3 Intercept Pharmaceuticals Bile Duct Cancer Drugs Introduction
11.11.4 Intercept Pharmaceuticals Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.11.5 Intercept Pharmaceuticals Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Bile Duct Cancer Drugs Introduction
11.12.4 Novartis Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.12.5 Novartis Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Bile Duct Cancer Drugs Introduction
11.13.4 Sanofi Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 Kyowa Hakko Kirin
11.14.1 Kyowa Hakko Kirin Company Details
11.14.2 Kyowa Hakko Kirin Business Overview
11.14.3 Kyowa Hakko Kirin Bile Duct Cancer Drugs Introduction
11.14.4 Kyowa Hakko Kirin Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.14.5 Kyowa Hakko Kirin Recent Development
11.15 Delcath Systems
11.15.1 Delcath Systems Company Details
11.15.2 Delcath Systems Business Overview
11.15.3 Delcath Systems Bile Duct Cancer Drugs Introduction
11.15.4 Delcath Systems Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.15.5 Delcath Systems Recent Development
11.16 Fresenius Kabi
11.16.1 Fresenius Kabi Company Details
11.16.2 Fresenius Kabi Business Overview
11.16.3 Fresenius Kabi Bile Duct Cancer Drugs Introduction
11.16.4 Fresenius Kabi Revenue in Bile Duct Cancer Drugs Business (2016-2021)
11.16.5 Fresenius Kabi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bile Duct Cancer Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 5-Fluorouracil (5-FU)
Table 3. Key Players of Gemcitabine
Table 4. Key Players of Cisplatin
Table 5. Key Players of Capecitabine
Table 6. Key Players of Oxaliplatin
Table 7. Key Players of Others
Table 8. Global Bile Duct Cancer Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bile Duct Cancer Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Bile Duct Cancer Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Bile Duct Cancer Drugs Market Share by Regions (2016-2021)
Table 12. Global Bile Duct Cancer Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Bile Duct Cancer Drugs Market Share by Regions (2022-2027)
Table 14. Bile Duct Cancer Drugs Market Trends
Table 15. Bile Duct Cancer Drugs Market Drivers
Table 16. Bile Duct Cancer Drugs Market Challenges
Table 17. Bile Duct Cancer Drugs Market Restraints
Table 18. Global Bile Duct Cancer Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Bile Duct Cancer Drugs Market Share by Players (2016-2021)
Table 20. Global Top Bile Duct Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer Drugs as of 2020)
Table 21. Ranking of Global Top Bile Duct Cancer Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Bile Duct Cancer Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Bile Duct Cancer Drugs Product Solution and Service
Table 25. Date of Enter into Bile Duct Cancer Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bile Duct Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Bile Duct Cancer Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Bile Duct Cancer Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Bile Duct Cancer Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Bile Duct Cancer Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Bile Duct Cancer Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Bile Duct Cancer Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Bile Duct Cancer Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Bile Duct Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Bile Duct Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Bile Duct Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Bile Duct Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Bile Duct Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Bile Duct Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Bile Duct Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Bile Duct Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Bile Duct Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Bile Duct Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Bile Duct Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Bile Duct Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bile Duct Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bile Duct Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bile Duct Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Bile Duct Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Bile Duct Cancer Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Bile Duct Cancer Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Bile Duct Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Bile Duct Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Bile Duct Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Bile Duct Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Bile Duct Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Bile Duct Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bile Duct Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bile Duct Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bile Duct Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Bile Duct Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Bile Duct Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Bile Duct Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Celgene Company Details
Table 66. Celgene Business Overview
Table 67. Celgene Bile Duct Cancer Drugs Product
Table 68. Celgene Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 69. Celgene Recent Development
Table 70. Mylan Company Details
Table 71. Mylan Business Overview
Table 72. Mylan Bile Duct Cancer Drugs Product
Table 73. Mylan Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 74. Mylan Recent Development
Table 75. Eli Lilly Company Details
Table 76. Eli Lilly Business Overview
Table 77. Eli Lilly Bile Duct Cancer Drugs Product
Table 78. Eli Lilly Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 79. Eli Lilly Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Bile Duct Cancer Drugs Product
Table 83. Johnson & Johnson Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Accord Healthcare Company Details
Table 86. Accord Healthcare Business Overview
Table 87. Accord Healthcare Bile Duct Cancer Drugs Product
Table 88. Accord Healthcare Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 89. Accord Healthcare Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Bile Duct Cancer Drugs Product
Table 93. Roche Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 94. Roche Recent Development
Table 95. Teva Company Details
Table 96. Teva Business Overview
Table 97. Teva Bile Duct Cancer Drugs Product
Table 98. Teva Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 99. Teva Recent Development
Table 100. AbbVie Company Details
Table 101. AbbVie Business Overview
Table 102. AbbVie Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 103. AbbVie Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Bile Duct Cancer Drugs Product
Table 107. Bristol-Myers Squibb Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Bile Duct Cancer Drugs Product
Table 112. Pfizer Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 113. Pfizer Recent Development
Table 114. Intercept Pharmaceuticals Company Details
Table 115. Intercept Pharmaceuticals Business Overview
Table 116. Intercept Pharmaceuticals Bile Duct Cancer Drugs Product
Table 117. Intercept Pharmaceuticals Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 118. Intercept Pharmaceuticals Recent Development
Table 119. Novartis Company Details
Table 120. Novartis Business Overview
Table 121. Novartis Bile Duct Cancer Drugs Product
Table 122. Novartis Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 123. Novartis Recent Development
Table 124. Sanofi Company Details
Table 125. Sanofi Business Overview
Table 126. Sanofi Bile Duct Cancer Drugs Product
Table 127. Sanofi Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 128. Sanofi Recent Development
Table 129. Kyowa Hakko Kirin Company Details
Table 130. Kyowa Hakko Kirin Business Overview
Table 131. Kyowa Hakko Kirin Bile Duct Cancer Drugs Product
Table 132. Kyowa Hakko Kirin Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 133. Kyowa Hakko Kirin Recent Development
Table 134. Delcath Systems Company Details
Table 135. Delcath Systems Business Overview
Table 136. Delcath Systems Bile Duct Cancer Drugs Product
Table 137. Delcath Systems Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 138. Delcath Systems Recent Development
Table 139. Fresenius Kabi Company Details
Table 140. Fresenius Kabi Business Overview
Table 141. Fresenius Kabi Bile Duct Cancer Drugs Product
Table 142. Fresenius Kabi Revenue in Bile Duct Cancer Drugs Business (2016-2021) & (US$ Million)
Table 143. Fresenius Kabi Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bile Duct Cancer Drugs Market Share by Type: 2020 VS 2027
Figure 2. 5-Fluorouracil (5-FU) Features
Figure 3. Gemcitabine Features
Figure 4. Cisplatin Features
Figure 5. Capecitabine Features
Figure 6. Oxaliplatin Features
Figure 7. Others Features
Figure 8. Global Bile Duct Cancer Drugs Market Share by Application: 2020 VS 2027
Figure 9. Hospitals & Clinic Case Studies
Figure 10. Cancer Treatment Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Bile Duct Cancer Drugs Report Years Considered
Figure 13. Global Bile Duct Cancer Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Bile Duct Cancer Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Bile Duct Cancer Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Bile Duct Cancer Drugs Market Share by Regions (2022-2027)
Figure 17. Global Bile Duct Cancer Drugs Market Share by Players in 2020
Figure 18. Global Top Bile Duct Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Bile Duct Cancer Drugs Revenue in 2020
Figure 20. Global Bile Duct Cancer Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Bile Duct Cancer Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Bile Duct Cancer Drugs Market Share by Type (2016-2027)
Figure 24. North America Bile Duct Cancer Drugs Market Share by Application (2016-2027)
Figure 25. North America Bile Duct Cancer Drugs Market Share by Country (2016-2027)
Figure 26. United States Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Bile Duct Cancer Drugs Market Share by Type (2016-2027)
Figure 30. Europe Bile Duct Cancer Drugs Market Share by Application (2016-2027)
Figure 31. Europe Bile Duct Cancer Drugs Market Share by Country (2016-2027)
Figure 32. Germany Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Bile Duct Cancer Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Bile Duct Cancer Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Bile Duct Cancer Drugs Market Share by Region (2016-2027)
Figure 42. China Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Bile Duct Cancer Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Bile Duct Cancer Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Bile Duct Cancer Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Bile Duct Cancer Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Bile Duct Cancer Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Bile Duct Cancer Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Bile Duct Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Celgene Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 65. Accord Healthcare Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 67. Teva Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 68. AbbVie Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 71. Intercept Pharmaceuticals Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 72. Novartis Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 73. Sanofi Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 74. Kyowa Hakko Kirin Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 75. Delcath Systems Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 76. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の胆管がん用治療薬市場規模・現状・予測（2021年-2027年） Bile Duct Cancer is a rare type of cancer that mainly affects adults aged over 65. Bile ducts are small tubes that connect the liver and small intestine that allow fluid called bile to flow from the liver, through the pancreas, to the gut, where it helps with digestion. Market Analysis and Insights:…- 世界の膵臓＆胆管がん治療薬市場規模・現状・予測（2021年-2027年） It is a drug for treating pancreatic cancer with bile duct cancer. Pancreatic cancer is a disease in which malignant (cancer) cells are found in pancreatic tissue. The pancreas is a large gland located in the abdominal cavity and is responsible for the secretion of digestive juice and insulin. Sympt…
- 胆管がん治療薬のグローバル市場調査 2019年 The global Bile Duct Cancer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Bile Duct Cancer Drug volume and value at global level, regional level and company level. From a global perspective, …
- 世界の食道がん治療薬市場規模・現状・予測（2021年-2027年） Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …
- 世界のがん支持療法薬剤市場規模・現状・予測（2021年-2027年） Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy. Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailore…